vs
NovoCure Ltd（NVCR）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
LiveRamp Holdings, Inc.的季度营收约是NovoCure Ltd的1.2倍（$212.2M vs $174.1M），LiveRamp Holdings, Inc.净利率更高（18.8% vs -40.9%，领先59.7%），NovoCure Ltd同比增速更快（12.3% vs 8.6%），过去两年LiveRamp Holdings, Inc.的营收复合增速更高（11.1% vs 7.6%）
NovoCure Ltd是一家全球肿瘤医疗企业，专注研发肿瘤治疗电场（TTFields）技术，推出可穿戴非侵入式癌症治疗设备，已获批用于胶质母细胞瘤、恶性胸膜间皮瘤、非小细胞肺癌等多个癌种，业务覆盖北美、欧洲及亚太地区。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
NVCR vs RAMP — 直观对比
营收规模更大
RAMP
是对方的1.2倍
$174.1M
营收增速更快
NVCR
高出3.7%
8.6%
净利率更高
RAMP
高出59.7%
-40.9%
两年增速更快
RAMP
近两年复合增速
7.6%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $174.1M | $212.2M |
| 净利润 | $-71.1M | $39.9M |
| 毛利率 | 77.6% | 71.9% |
| 营业利润率 | — | 18.6% |
| 净利率 | -40.9% | 18.8% |
| 营收同比 | 12.3% | 8.6% |
| 净利润同比 | -107.3% | 255.7% |
| 每股收益（稀释后） | — | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NVCRRAMP
| Q1 26 | $174.1M | — | ||
| Q4 25 | $174.3M | $212.2M | ||
| Q3 25 | $167.2M | $199.8M | ||
| Q2 25 | $158.8M | $194.8M | ||
| Q1 25 | $155.0M | $188.7M | ||
| Q4 24 | $161.3M | $195.4M | ||
| Q3 24 | $155.1M | $185.5M | ||
| Q2 24 | $150.4M | $176.0M |
净利润NVCRRAMP
| Q1 26 | $-71.1M | — | ||
| Q4 25 | $-24.5M | $39.9M | ||
| Q3 25 | $-37.3M | $27.4M | ||
| Q2 25 | $-40.1M | $7.7M | ||
| Q1 25 | $-34.3M | $-6.3M | ||
| Q4 24 | $-65.9M | $11.2M | ||
| Q3 24 | $-30.6M | $1.7M | ||
| Q2 24 | $-33.4M | $-7.5M |
毛利率NVCRRAMP
| Q1 26 | 77.6% | — | ||
| Q4 25 | 75.8% | 71.9% | ||
| Q3 25 | 73.2% | 70.2% | ||
| Q2 25 | 73.9% | 70.1% | ||
| Q1 25 | 75.1% | 69.3% | ||
| Q4 24 | 79.2% | 71.9% | ||
| Q3 24 | 77.2% | 72.4% | ||
| Q2 24 | 77.0% | 70.6% |
营业利润率NVCRRAMP
| Q1 26 | — | — | ||
| Q4 25 | -23.2% | 18.6% | ||
| Q3 25 | -21.5% | 10.7% | ||
| Q2 25 | -24.9% | 3.7% | ||
| Q1 25 | -24.4% | -6.1% | ||
| Q4 24 | -39.3% | 7.5% | ||
| Q3 24 | -20.7% | 4.0% | ||
| Q2 24 | -22.3% | -3.0% |
净利率NVCRRAMP
| Q1 26 | -40.9% | — | ||
| Q4 25 | -14.1% | 18.8% | ||
| Q3 25 | -22.3% | 13.7% | ||
| Q2 25 | -25.3% | 4.0% | ||
| Q1 25 | -22.1% | -3.3% | ||
| Q4 24 | -40.9% | 5.7% | ||
| Q3 24 | -19.7% | 0.9% | ||
| Q2 24 | -22.2% | -4.3% |
每股收益（稀释后）NVCRRAMP
| Q1 26 | — | — | ||
| Q4 25 | $-0.22 | $0.62 | ||
| Q3 25 | $-0.33 | $0.42 | ||
| Q2 25 | $-0.36 | $0.12 | ||
| Q1 25 | $-0.31 | $-0.10 | ||
| Q4 24 | $-0.61 | $0.17 | ||
| Q3 24 | $-0.28 | $0.03 | ||
| Q2 24 | $-0.31 | $-0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $432.0M | $403.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $330.7M | $962.3M |
| 总资产 | $787.9M | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NVCRRAMP
| Q1 26 | $432.0M | — | ||
| Q4 25 | $93.5M | $403.4M | ||
| Q3 25 | $342.1M | $376.9M | ||
| Q2 25 | $149.6M | $371.1M | ||
| Q1 25 | $127.3M | $420.8M | ||
| Q4 24 | $163.8M | $384.3M | ||
| Q3 24 | $185.4M | $348.4M | ||
| Q2 24 | $164.8M | $342.7M |
股东权益NVCRRAMP
| Q1 26 | $330.7M | — | ||
| Q4 25 | $340.5M | $962.3M | ||
| Q3 25 | $341.3M | $943.8M | ||
| Q2 25 | $349.4M | $947.8M | ||
| Q1 25 | $362.0M | $948.9M | ||
| Q4 24 | $360.2M | $957.7M | ||
| Q3 24 | $360.8M | $932.1M | ||
| Q2 24 | $361.8M | $951.9M |
总资产NVCRRAMP
| Q1 26 | $787.9M | — | ||
| Q4 25 | $804.3M | $1.3B | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.2B | $1.3B | ||
| Q4 24 | $1.2B | $1.3B | ||
| Q3 24 | $1.2B | $1.2B | ||
| Q2 24 | $1.2B | $1.2B |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
